FIBROGEN INC Contracts & Agreements

96 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Amendment to Financing Agreement among FibroGen, Inc., Wilmington Trust, and Lenders
Financing Agreements
FIBROGEN INC
Biotechnology
NY
2025
FibroGen, Inc. Insider Trading and Trading Window Policy (Amended and Restated November 2021)
Code of Ethics
FIBROGEN INC
Biotechnology
2025
ATM Equity Offering Sales Agreement between FibroGen, Inc. and BofA Securities, Inc. dated February 24, 2025
Equity Distribution Agreements
FIBROGEN INC
Biotechnology
DE
2025
Amendment No. 1 to Exclusive License and Option Agreement between HiFiBiO Inc. and FibroGen, Inc.
License Agreements
FIBROGEN INC
Biotechnology
2024
Termination Agreement between FibroGen, Inc. and AstraZeneca AB (February 25, 2024)
Termination Agreements
FIBROGEN INC
Biotechnology
2024
FibroGen, Inc. Employment Offer Letter to Deyaa R. Adib, MD for SVP, Chief Medical Officer Position
Employment Agreements
FIBROGEN INC
Biotechnology
CA
2024
Amendment No. 1 to Second Amended and Restated Exclusive License Agreement between FibroGen (China) Medical Technology Development Co., Ltd. and Eluminex Biosciences (Suzhou)...
License Agreements
FIBROGEN INC
Biotechnology
2024
Second Amended and Restated Exclusive License Agreement between FibroGen, Inc. and Eluminex Biosciences (Suzhou) Limited
License Agreements
FIBROGEN INC
Biotechnology
NY
2023
FibroGen, Inc. Interim CEO Employment Offer Letter to Thane Wettig (July 2023)
Employment Agreements
FIBROGEN INC
Biotechnology
2023
Amended and Restated Exclusive License Agreement between FibroGen, Inc. and Eluminex Biosciences (Suzhou) Limited
License Agreements
FIBROGEN INC
Biotechnology
NY
2022
Exclusive License Agreement between FibroGen, Inc. and Eluminex Biosciences (Suzhou) Limited
License Agreements
FIBROGEN INC
Biotechnology
NY
2021
FibroGen, Inc. Chief Financial Officer Employment Offer Letter to Juan Graham
Employment Agreements
FIBROGEN INC
Biotechnology
2021
Exclusive License and Option Agreement between FibroGen, Inc. and HiFiBiO (HK) Limited (HiFiBiO Therapeutics)
License Agreements
FIBROGEN INC
Biotechnology
IL
2021
FibroGen, Inc. Chief Medical Officer Employment Offer Letter to Mark Eisner, M.D., M.P.H.
Employment Agreements
FIBROGEN INC
Biotechnology
2021
FibroGen, Inc. Chief Commercial Officer Employment Offer Letter to Thane Wettig (May 7, 2020)
Employment Agreements
FIBROGEN INC
Biotechnology
2020
Second Amended and Restated License, Development and Commercialization Agreement (China) between FibroGen China Entities and AstraZeneca AB
License Agreements
FIBROGEN INC
Biotechnology
CA
2020
Amendment No. 1 to Amended and Restated License, Development and Commercialization Agreement between FibroGen, Inc. and AstraZeneca AB
License Agreements
FIBROGEN INC
Biotechnology
2020
Description of Capital Stock of [Company Name]
Stock Agreements
FIBROGEN INC
Biotechnology
2020
FibroGen, Inc. Employment Offer Letter to Christine Chung (Senior Director, China)
Employment Agreements
FIBROGEN INC
Biotechnology
2020
FibroGen, Inc. Employment Offer Letter to Elias Kouchakji, MD for Vice President, Drug Safety Position
Employment Agreements
FIBROGEN INC
Biotechnology
2020
FibroGen, Inc. Chief Executive Officer Employment Offer Letter with Enrique Conterno
Employment Agreements
FIBROGEN INC
Biotechnology
2020
FibroGen, Inc. Interim CEO Employment Offer Letter with James Schoeneck (2019)
Employment Agreements
FIBROGEN INC
Biotechnology
2019
Materials Transfer Agreement Letter between FibroGen Inc. and Astellas Pharma Inc.
Collaboration Agreements
FIBROGEN INC
Biotechnology
2018
FibroGen International (Cayman) Limited Shareholders’ Agreement Dated September 8, 2017
Shareholders Agreements
FIBROGEN INC
Biotechnology
DE
2017
Underwriting Agreement between FibroGen, Inc. and Underwriters (Goldman Sachs, Citigroup, Leerink Partners) dated August 15, 2017
Underwriting Agreements
FIBROGEN INC
Biotechnology
DE
2017
State-Owned Construction Land Use Right Granting Contract between Bureau of Land and Resources of Cangzhou and FibroGen (China) Medical Technology Development Co., Ltd.
Lease Agreements
FIBROGEN INC
Biotechnology
2017
Underwriting Agreement between FibroGen, Inc. and Underwriters (Leerink Partners LLC, Stifel, Nicolaus & Company, Incorporated) dated April 5, 2017
Underwriting Agreements
FIBROGEN INC
Biotechnology
DE
2017
FibroGen, Inc. Common Stock Certificate
Stock Agreements
FIBROGEN INC
Biotechnology
NY
2014
Underwriting Agreement between FibroGen, Inc. and Underwriters (Goldman Sachs, Citigroup, Leerink Partners) for Common Stock Offering
Underwriting Agreements
FIBROGEN INC
Biotechnology
DE
2014
FibroGen, Inc. Common Stock Certificate Issued by Wells Fargo Bank, N.A. as Transfer Agent
Stock Agreements
FIBROGEN INC
Biotechnology
NY
2014
FibroGen, Inc. 2014 Equity Incentive Plan
Equity Distribution Agreements
FIBROGEN INC
Biotechnology
DE
2014
FibroGen, Inc. 2014 Employee Stock Purchase Plan
Stock Agreements
FIBROGEN INC
Biotechnology
2014
Amended and Restated License, Development and Commercialization Agreement between FibroGen, Inc. and AstraZeneca AB
License Agreements
FIBROGEN INC
Biotechnology
CA
2014
Common Stock Purchase Agreement between FibroGen, Inc. and AstraZeneca AB dated October 20, 2014
Purchase Agreements
FIBROGEN INC
Biotechnology
CA
2014
FibroGen, Inc. 2014 Equity Incentive Plan
Equity Distribution Agreements
FIBROGEN INC
Biotechnology
DE
2014
FibroGen, Inc. 2014 Employee Stock Purchase Plan
Equity Distribution Agreements
FIBROGEN INC
Biotechnology
2014
Amended and Restated License, Development and Commercialization Agreement (China) between FibroGen China Entities and AstraZeneca AB
License Agreements
FIBROGEN INC
Biotechnology
CA
2014
Indemnity Agreement between FibroGen, Inc. and Indemnitee
Indemnification Agreements
FIBROGEN INC
Biotechnology
DE
2014
Amended and Restated License, Development and Commercialization Agreement between FibroGen, Inc. and AstraZeneca AB
License Agreements
FIBROGEN INC
Biotechnology
CA
2014
Investor Rights Agreement between FibroGen, Inc. and Investors (December 1995)
Investor Rights Agreements
FIBROGEN INC
Biotechnology
DE
2014
FibroGen, Inc. Investor Rights Agreement with Investors Dated February 20, 1998
Investor Rights Agreements
FIBROGEN INC
Biotechnology
DE
2014
FibroGen, Inc. Investors' Rights Agreement with Series E Preferred Stock Purchasers (May 12, 2000)
Investor Rights Agreements
FIBROGEN INC
Biotechnology
CA
2014
FibroGen, Inc. Bonus Plan for Employees (2024)
Bonus & Incentive Agreements
FIBROGEN INC
Biotechnology
2025
First Amended and Restated Evaluation Agreement between FibroGen, Inc. and Fortis Therapeutics, Inc. (June 6, 2024)
Collaboration Agreements
FIBROGEN INC
Biotechnology
CA
2024
FibroGen, Inc. 2024 Equity Incentive Plan
Bonus & Incentive Agreements
FIBROGEN INC
Biotechnology
NY
2024
FibroGen, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
FIBROGEN INC
Biotechnology
2024
FibroGen, Inc. Bonus Plan for Employees (2024)
Bonus & Incentive Agreements
FIBROGEN INC
Biotechnology
2024
Consulting Agreement between FibroGen, Inc. and Mark Eisner dated September 11, 2023
Consulting Agreements
FIBROGEN INC
Biotechnology
CA
2023
Consulting Agreement between FibroGen, Inc. and Enrique Conterno (Effective August 9, 2023)
Consulting Agreements
FIBROGEN INC
Biotechnology
CA
2023
Amendment No. 4 to Master Supply Agreement between FibroGen, Inc. and STA Pharmaceutical Entities
Supply Agreements
FIBROGEN INC
Biotechnology
2022
Transition Agreement between Pat Cotroneo and FibroGen, Inc. (August 14, 2021)
Transition Agreements
FIBROGEN INC
Biotechnology
CA
2021
Sixth Amendment to Lease Agreement between ARE-San Francisco No. 43, LLC and FibroGen, Inc.
Lease Agreements
FIBROGEN INC
Biotechnology
2021
Transition, Separation, and Consulting Agreement between FibroGen, Inc. and K. Peony Yu
Separation Agreements
FIBROGEN INC
Biotechnology
CA
2021
Astellas EU Supply Agreement between FibroGen, Inc. and Astellas Pharma Europe Ltd (Effective January 1, 2021)
Supply Agreements
FIBROGEN INC
Biotechnology
2021
Amendment No. 3 to Master Supply Agreement between FibroGen, Inc. and STA Pharmaceutical Entities
Supply Agreements
FIBROGEN INC
Biotechnology
2021
Master Services Agreement between Samsung Biologics Co., Ltd. and FibroGen, Inc.
Services Agreements
FIBROGEN INC
Biotechnology
IL
2021
Product Specific Agreement for Clinical Drug Substance Manufacturing between FibroGen, Inc. and Samsung Biologics Co., Ltd.
Services Agreements
FIBROGEN INC
Biotechnology
2021
Collaboration Agreement between FibroGen, Inc. and Astellas Pharma Inc. (June 1, 2005)
Collaboration Agreements
FIBROGEN INC
Biotechnology
CA
2020
Amendment No. 1 to Master Supply Agreement between FibroGen, Inc. and STA Pharmaceutical Entities
Supply Agreements
FIBROGEN INC
Biotechnology
2020
FibroGen, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
FIBROGEN INC
Biotechnology
2020
Commercial Supply Agreement between FibroGen, Inc. and Catalent Pharma Solutions, LLC for Roxadustat
Supply Agreements
FIBROGEN INC
Biotechnology
2020
FibroGen, Inc. CEO Change in Control and Severance Agreement
Change of Control Agreements
FIBROGEN INC
Biotechnology
CA
2020
FibroGen, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
FIBROGEN INC
Biotechnology
2019
FibroGen, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
FIBROGEN INC
Biotechnology
2019
Amendment No. 33 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Development Agreements
FIBROGEN INC
Biotechnology
2019
Amendment No. 1 to Collaboration Agreement between Astellas Pharma Inc. and FibroGen, Inc.
Collaboration Agreements
FIBROGEN INC
Biotechnology
2019
FibroGen, Inc. Non-Employee Director Compensation Policy (as Amended)
Compensation Agreements
FIBROGEN INC
Biotechnology
2018
API Batch Transfer Price Agreement between FibroGen, Inc. and Astellas Pharma, Inc. (June 15, 2018)
Supply Agreements
FIBROGEN INC
Biotechnology
2018
Amendment No. 32 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Development Agreements
FIBROGEN INC
Biotechnology
2018
Work Order No. 1 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Services Agreements
FIBROGEN INC
Biotechnology
2018
FibroGen, Inc. Employee Bonus Plan
Bonus & Incentive Agreements
FIBROGEN INC
Biotechnology
2018
Collaboration Agreement between FibroGen, Inc. and Astellas Pharma Inc. (June 1, 2005)
Collaboration Agreements
FIBROGEN INC
Biotechnology
CA
2017
Amendment No. 31 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2017
FibroGen, Inc. Change in Control and Severance Agreement with Executive
Change of Control Agreements
FIBROGEN INC
Biotechnology
CA
2017
Amendment No. 29 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2017
Amendment No. 30 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Services Agreements
FIBROGEN INC
Biotechnology
2017
Amendment No. 27 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 28 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 22 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Development Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 24 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 25 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Development Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 26 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2016
FibroGen, Inc. Incentive Compensation Plan
Bonus & Incentive Agreements
FIBROGEN INC
Biotechnology
2016
FibroGen, Inc. Non-Employee Director Compensation Policy (as Amended)
Compensation Agreements
FIBROGEN INC
Biotechnology
2016
Amendment No. 15 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Amendment No. 16 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Seventeenth Amendment to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Amendment No. 18 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Amendment No. 19 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Twentieth Amendment to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Amendment No. 21 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Supply Agreements
FIBROGEN INC
Biotechnology
2015
Amendment No. 23 to Process Development and Clinical Supply Agreement between Boehringer Ingelheim Biopharmaceuticals GmbH and FibroGen, Inc.
Development Agreements
FIBROGEN INC
Biotechnology
2015
FibroGen, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
FIBROGEN INC
Biotechnology
2015
FibroGen 2014 Incentive Compensation Plan
Bonus & Incentive Agreements
FIBROGEN INC
Biotechnology
2014
FibroGen, Inc. Change in Control and Severance Agreement with Executive
Change of Control Agreements
FIBROGEN INC
Biotechnology
CA
2014
FibroGen, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
FIBROGEN INC
Biotechnology
2014